GoodRx Holdings, Inc.

NasdaqGS:GDRX Stock Report

Market Cap: US$794.8m

GoodRx Holdings Balance Sheet Health

Financial Health criteria checks 6/6

GoodRx Holdings has a total shareholder equity of $616.3M and total debt of $488.3M, which brings its debt-to-equity ratio to 79.2%. Its total assets and total liabilities are $1.4B and $787.8M respectively. GoodRx Holdings's EBIT is $106.2M making its interest coverage ratio 3.4. It has cash and short-term investments of $261.8M.

Key information

79.23%

Debt to equity ratio

US$488.26m

Debt

Interest coverage ratio3.4x
CashUS$261.82m
EquityUS$616.26m
Total liabilitiesUS$787.80m
Total assetsUS$1.40b

Recent financial health updates

Recent updates

GoodRx: Losing Relevance With Consumers (Downgrade)

Mar 09

Investors Don't See Light At End Of GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Tunnel And Push Stock Down 33%

Nov 01
Investors Don't See Light At End Of GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Tunnel And Push Stock Down 33%

Should You Think About Buying GoodRx Holdings, Inc. (NASDAQ:GDRX) Now?

Oct 02
Should You Think About Buying GoodRx Holdings, Inc. (NASDAQ:GDRX) Now?

GoodRx Holdings' (NASDAQ:GDRX) Performance Is Even Better Than Its Earnings Suggest

Aug 15
GoodRx Holdings' (NASDAQ:GDRX) Performance Is Even Better Than Its Earnings Suggest

Little Excitement Around GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Revenues As Shares Take 28% Pounding

Aug 08
Little Excitement Around GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Revenues As Shares Take 28% Pounding

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Jun 24
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

May 23
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital
User avatar

Pharma Manufacturer Solutions Expansion Will Improve Prescription Access

GoodRx aims to boost revenue by expanding Pharma Manufacturer Solutions and enhancing the prescription marketplace, aligning with partners' economic needs.

GoodRx: Great Value For Patient Investors (Upgrade)

Mar 24

GoodRx: A Business In Transition, But It Has Likely Reached Its Low (Rating Upgrade)

Jan 08

Capital Allocation Trends At GoodRx Holdings (NASDAQ:GDRX) Aren't Ideal

Dec 21
Capital Allocation Trends At GoodRx Holdings (NASDAQ:GDRX) Aren't Ideal

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

Oct 29
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade)

Oct 26

GoodRx Holdings: Failing To Gain Much Traction

Oct 08

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Sep 22
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

GoodRx Q2 Earnings Preview

Jul 31

GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

Jul 12
GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Jun 09
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

Jun 06
Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

Financial Position Analysis

Short Term Liabilities: GDRX's short term assets ($643.1M) exceed its short term liabilities ($246.0M).

Long Term Liabilities: GDRX's short term assets ($643.1M) exceed its long term liabilities ($541.8M).


Debt to Equity History and Analysis

Debt Level: GDRX's net debt to equity ratio (36.7%) is considered satisfactory.

Reducing Debt: GDRX's debt to equity ratio has reduced from 93.8% to 79.2% over the past 5 years.

Debt Coverage: GDRX's debt is well covered by operating cash flow (34.4%).

Interest Coverage: GDRX's interest payments on its debt are well covered by EBIT (3.4x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/16 10:55
End of Day Share Price 2026/04/16 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GoodRx Holdings, Inc. is covered by 25 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Glen SantangeloBarclays
Allen LutzBofA Global Research
Daniel GrosslightCitigroup Inc